Can a common antiviral save lives in advanced HIV?
Disease control
Not yet recruiting
This study tests whether valganciclovir, a drug that stops CMV from multiplying, can safely lower CMV levels in the blood of people with advanced HIV. About 130 adults and adolescents with very weak immune systems will be randomly assigned to take either valganciclovir or a place…
Phase: PHASE2 • Sponsor: Wits Health Consortium (Pty) Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC